{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:57:15Z","timestamp":1768453035946,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases","award":["U24-CA076518"],"award-info":[{"award-number":["U24-CA076518"]}]},{"name":"NHLBI and NCI","award":["5U10HL069294"],"award-info":[{"award-number":["5U10HL069294"]}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201200016C"],"award-info":[{"award-number":["HHSH250201200016C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-13-1-0039"],"award-info":[{"award-number":["N00014-13-1-0039"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-14-1-0028"],"award-info":[{"award-number":["N00014-14-1-0028"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010535","name":"Actinium Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010535","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010299","name":"Allos Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010299","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006413","name":"Ariad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001738","name":"Be the Match Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007501","name":"Blue Cross and Blue Shield Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016875","name":"Chimerix, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016875","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fresenius-Biotech North America, Inc."},{"name":"Gamida Cell Teva Joint Venture Ltd."},{"DOI":"10.13039\/100004328","name":"Genentech, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gentium SpA"},{"DOI":"10.13039\/100004329","name":"Genzyme Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research, Inc. Roswell Park Cancer Institute"},{"name":"HistoGenetics, Inc."},{"name":"Incyte Corporation"},{"name":"Jeff Gordon Children's Foundation"},{"DOI":"10.13039\/501100004072","name":"Kiadis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"The Leukemia & Lymphoma Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014841","name":"Medac GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Medical College of Wisconsin"},{"name":"Merck & Co, Inc."},{"DOI":"10.13039\/100011957","name":"The Takeda Oncology Co.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Milliman USA, Inc."},{"name":"Miltenyi Biotec, Inc."},{"DOI":"10.13039\/100007072","name":"Onyx Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007072","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Optum Healthcare Solutions, Inc."},{"DOI":"10.13039\/100007075","name":"Osiris Therapeutics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007075","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009155","name":"Otsuka America Pharmaceutical, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009155","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Perkin Elmer, Inc."},{"name":"Remedy Informatics"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009996","name":"Sigma-Tau Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009996","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soligenix, Inc."},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008761","name":"StemCyte, A Global Cord Blood Therapeutics Co.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stemsoft Software, Inc."},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007127","name":"Tarix Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007127","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TerumoBCT"},{"name":"Teva Neuroscience, Inc."},{"DOI":"10.13039\/100007163","name":"THERAKOS, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007163","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004382","name":"Wellpoint, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbmt.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T02:17:55Z","timestamp":1477275475000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Allogeneic Transplantation for Relapsed Waldenstr\u00f6m Macroglobulinemia and Lymphoplasmacytic Lymphoma"],"prefix":"10.1016","volume":"23","author":[{"given":"Robert F.","family":"Cornell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang","family":"Woo-Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Samer","family":"Al-Homsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-Angel","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar O.","family":"Freytes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rammurti T.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamila","family":"Kindwall-Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Vesole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Yared","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomer","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yago","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parameswaran","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.10.010_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/ijh.14.5","article-title":"Why Waldenstr\u00f6m macroglobulinemia is not just another indolent lymphoma","volume":"3","author":"Cornell","year":"2014","journal-title":"Int J Hematol Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0015","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V82.10.3148.3148","article-title":"Incidence of Waldenstrom's macroglobulinemia","volume":"82","author":"Herrinton","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0025","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood.V122.21.3135.3135","article-title":"Changing epidemiology and improved survival in patients with Waldenstrom macroglobulinemia: review of surveillance, epidemiology, and end results (SEER) data","volume":"122","author":"Boise","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.leukres.2010.04.005","article-title":"Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)","volume":"34","author":"Kastritis","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0035","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0040","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3324\/haematol.12846","article-title":"The International Prognostic Scoring System for Waldenstr\u00f6m's macroglobulinemia is applicable in patients treated with rituximab-based regimens","volume":"93","author":"Dimopoulos","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2016.04.019","article-title":"Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: increasingly successful application to older patients","volume":"22","author":"Fenske","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1705702","article-title":"Long-term graft-versus-Waldenstrom macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation","volume":"40","author":"Meniane","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/sonc.2003.50048","article-title":"Transplantation in Waldenstrom's macroglobulinemia\u2014the French experience","volume":"30","author":"Tournilhac","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1701633","article-title":"Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia","volume":"23","author":"Martino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2006.04.010","article-title":"Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia","volume":"12","author":"Anagnostopoulos","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0070","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1200\/JCO.2009.27.3607","article-title":"Allogeneic stem-cell transplantation in patients with Waldenstrom macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Kyriakou","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0075","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","article-title":"Treatment recommendations for patients with Waldenstr\u00f6m macroglobulinemia (WM) and related disorders: IWWM-7 consensus","volume":"124","author":"Dimopoulos","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3816\/CLM.2006.n.013","article-title":"Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia","volume":"6","author":"Kimby","year":"2006","journal-title":"Clin Lymph Myelom"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0090","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0100","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.3324\/haematol.2015.137265","article-title":"Ibrutinib and idelalisib target B cell receptor- but not CXCL12\/CXCR4-controlled integrin-mediated adhesion in Waldenstr\u00f6m macroglobulinemia","volume":"101","author":"de Rooij","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdv572","article-title":"Waldenstrom's macroglobulinemia: a clinical perspective in the era of novel therapeutics","volume":"27","author":"Dimopoulos","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0110","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in previously treated Waldenstrom's macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.23922","article-title":"Waldenstrom macroglobulinemia: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gertz","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2014-03-566273","article-title":"Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstrom's macroglobulinemia","volume":"124","author":"Treon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0125","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2008.20.4677","article-title":"Primary therapy of Waldenstrom macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180","volume":"27","author":"Treon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.2000.18.1.214","article-title":"Waldenstrom's macroglobulinemia: clinical features, complications, and management","volume":"18","author":"Dimopoulos","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0135","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3324\/haematol.2009.017814","article-title":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstrom's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","volume":"95","author":"Garnier","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0140","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood.V108.11.3034.3034","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) for refractory Waldenstrom's macroglobulinemia (WM): evidence for a graft-versus-WM effect","volume":"108","author":"Anderson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bjh.14046","article-title":"Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation","volume":"174","author":"Fenske","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.10.010_bib0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood-2005-02-0596","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan","volume":"108","author":"Kim","year":"2006","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116304244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116304244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:56:53Z","timestamp":1761058613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116304244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1083879116304244"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Transplantation for Relapsed Waldenstr\u00f6m Macroglobulinemia and Lymphoplasmacytic Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}